Pathology: Thoracic and Genitourinary Translational Team
Dr. Levi’s clinical research and the implementation of automation in Pap test screening in the Yale cytology division has lead to improvements in the Pap test QA/QC program, cytotechnologist workload, laboratory efficiency, and the turn-around-time of Pap test results. Additionally, her clinical research and the implementation of concurrent molecular testing from liquid-based Pap tests has aided in outpatient gynecologic care and clinical management of infectious vaginitis/cervical disease and human papillomavirus-related cervical dysplasia. Building on her previous experience at a private sector pathology laboratory that studied prostate cancer biomarkers with image analysis, her research interests also include prostate cancer pathology and correlation with image analysis.
A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Arch Pathol Lab Med. 2016 Feb;140(2):153-7. doi: 10.5858/arpa.2015-0027-OA.
Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin.
Am J Clin Pathol. 2015 May;143(5):694-700. doi: 10.1309/AJCPCZA4PSZCFHQ4.
Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
Arch Pathol Lab Med. 2015 Feb;139(2):184-8. doi: 10.5858/arpa.2014-0028-OA.
Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Cancer Prev Res (Phila). 2014 May;7(5):526-33.